ACRS
Aclaris Therapeutics Inc
5.40$
+1.5%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 71.7% | 67.9% | 95.9% | 79.2% | 69.7% | 40.2% | 57.9% | 14.9% | 26.7% | |
| – | – | – | 28.3% | 32.1% | 4.1% | 20.8% | 30.3% | 59.8% | 42.1% | 85.1% | 73.3% | |
| – | – | – | 2,364.2% | 624.4% | 1,535.3% | 489.5% | 648.0% | 261.5% | 314.8% | 179.4% | 672.7% | |
| – | – | – | 1,967.3% | 274.0% | 642.4% | 316.7% | 349.3% | 84.5% | 99.5% | 118.6% | 280.8% | |
| – | – | – | 4,331.5% | 1,374.0% | 2,193.7% | 806.2% | 1,357.4% | 361.8% | 353.7% | 843.3% | 1,049.2% | |
| – | – | – | -4,303.2% | -1,341.9% | -2,627.3% | -785.4% | -1,327.1% | -302.0% | -311.6% | -758.2% | -975.9% | |
| – | – | – | 0.0% | 0.0% | 0.0% | 16.0% | 346.3% | 15.8% | – | – | – | |
| – | – | – | -4,180.2% | -1,315.4% | -2,686.1% | -792.0% | -1,344.0% | -292.1% | -284.3% | -705.5% | -829.6% | |
| – | – | – | -108.7% | 26.5% | 693.4% | -2.8% | 346.3% | 5.9% | -1.2% | – | – | |
| – | – | – | -4,071.5% | -1,315.4% | -3,817.2% | -789.2% | -1,344.0% | -292.1% | -283.1% | -705.5% | -829.6% | |
| – | – | – | -4,279.3% | -1,323.3% | -2,134.7% | -765.0% | -953.4% | -283.5% | -369.5% | -276.3% | -823.8% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.